Загрузка...
Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine
INTRODUCTION: Iron overload is the primary cause of mortality and morbidity in thalassemia major (TM) despite advances in chelation therapy. The aim of this study was to compare the effectiveness and safety of deferasirox (DFX) and deferoxamine (DFO) as iron-chelating agents in patients with transfu...
Сохранить в:
| Опубликовано в: : | Electron Physician |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Electronic physician
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4930264/ https://ncbi.nlm.nih.gov/pubmed/27382454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.19082/2425 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|